Guest: Dr. Luis Diaz
Presenter: Neal Howard
Guest Bio: Dr. Luis Diaz is a leading authority in oncology who has pioneered several genomic diagnostic and therapeutic approaches for cancer. He is head of the Division of Solid Tumor Oncology at the Memorial Sloan Kettering Cancer Center where he specializes in the treatment of advanced pancreatic and colorectal cancers. Prior to his role at MSKCC he was a member of the Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins and also directed the Swim Across America Lab. He is also founder of several entities that focus on genomic analyses of cancers, including Inostics, PapGene and Personal Genome Diagnostics (PGDx). Dr. Diaz has undergraduate and medical degrees from the University of Michigan, and completed residency training at the Osler Medical Service at Johns Hopkins and medical oncology training at the Sidney Kimmel Cancer Center at Johns Hopkins.
Segment overview: In this segment, Dr. Luis Diaz talks about the science of biomarkers, the clinical utility of MSI-H/dMMR, and how this development may provide new hope to some of the millions of people impacted by cancer.